trans-4,5-Epoxy-(E)-nonenal
Common Name: |
trans-4,5-Epoxy-(E)-nonenal |
IUPAC Name: |
(E)-3-(3-butyloxiran-2-yl)prop-2-enal |
Molecular Formula: |
C9H14O2 |
SMILES: |
CCCCC1C(O1)C=CC=O |
Inchi: |
1S/C9H14O2/c1-2-3-5-8-9(11-8)6-4-7-10/h4,6-9H,2-3,5H2,1H3/b6-4+ |
Inchi Key: |
JQNFKXWEJORMGJ-GQCTYLIASA-N |
Cas No: |
128386-31-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
154.21 |
Mass (g/mol) |
154.099 |
Molar Refractivity |
60.61 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
5 |
Rings |
|
TPSA |
29.60 |
Hetero Atoms |
|
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.75 |
LogP |
1.5 |
iLOGP |
2.93 |
XLOGP3 |
3.80 |
WLOGP |
3.47 |
MLOGP |
3.04 |
ESOL Log S |
-2.87 |
ESOL Solubility (mg/ml) |
0.268 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.05 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.27 |
Silicos-IT Solubility (mg/ml) |
0.11 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.81 |
Bioavailability Score |
0.55 |
Caco2 |
|
Human Intestinal Absorption |
|
Plasm Protein Binding |
|
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
|
Acute Oral Toxicity |
|
Carcinogenicity (Binary) |
|
Carcinogenicity (Trinary) |
null |
Eye Irritation |
|
Hepatotoxicity |
|
Androgen Receptor Binding |
|
Aromatase Binding |
|
Estrogen Receptor Binding |
|
Glucocorticoid Receptor Binding |
|
Thyroid Receptor Binding |
|
BRCP inhibitor |
|
BSEP inhibitor |
|
OATP1B1 inhibitor |
|
OATP1B3 inhibitor |
|
OATP2B1 inhibitor |
|
OCT1 inhibitor |
|
OCT2 inhibitor |
|